Gene · 4477
Papers2,399
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,399
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment. | Endocr Connect | 2022 | 35575351 | PubTator, text mining | PubMed |
| The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer. | Int J Mol Sci | 2022 | 35563163 | PubTator, text mining | PubMed |
| MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. | Nat Commun | 2022 | 35562350 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. | Sci Adv | 2022 | 35559673 | PubTator, text mining | PubMed |
| Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing. | Am J Respir Crit Care Med | 2022 | 35549656 | PubTator, text mining | PubMed |
| Methylation and Polymorphism in CDH1 Gene Promoter Among Patients with Diffuse Gastric Cancer. | Int J Prev Med | 2022 | 35529508 | PubTator, text mining | PubMed |
| EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients. | Front Cell Dev Biol | 2022 | 35517503 | PubTator, text mining | PubMed |
A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study. | Eur Urol Open Sci | 2022 | 35495282 | PubTator, text mining | PubMed |
| The Impact of Genes and Environment on Brain Ageing in Males Aged 51 to 72 Years. | Front Aging Neurosci | 2022 | 35493948 | PubTator, text mining | PubMed |
| Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen. | J Genet Eng Biotechnol | 2022 | 35482141 | PubTator, text mining | PubMed |
| Nitrogen self-doped carbon with super high-rate and long cycle life as anode materials for lithium-ion batteries. | RSC Adv | 2022 | 35480372 | PubTator, text mining | PubMed |
| Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. | J Hematol Oncol | 2022 | 35477416 | PubTator, text mining | PubMed |
| Exploring Wearables to Focus on the "Sweet Spot" of Physical Activity and Sleep After Hospitalization: Secondary Analysis. | JMIR Mhealth Uhealth | 2022 | 35476034 | PubTator, text mining | PubMed |
| 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism. | Mol Med | 2022 | 35468719 | PubTator, text mining | PubMed |
| The Development of Classical Swine Fever Marker Vaccines in Recent Years. | Vaccines (Basel) | 2022 | 35455351 | PubTator, text mining | PubMed |
| Comparative Genomics Reveals Genetic Diversity and Metabolic Potentials of the Genus Qipengyuania and Suggests Fifteen Novel Species. | Microbiol Spectr | 2022 | 35446150 | PubTator, text mining | PubMed |
| Epigenetic modification regulates tumor progression and metastasis through EMT (Review). | Int J Oncol | 2022 | 35445731 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Multiscale Transcriptomic Integration Reveals B-Cell Depletion and T-Cell Mistrafficking in Nasopharyngeal Carcinoma Progression. | Front Cell Dev Biol | 2022 | 35433690 | PubTator, text mining | PubMed |
| The dynamic alteration of transcriptional regulation by crucial TFs during tumorigenesis of gastric cancer. | Mol Med | 2022 | 35421923 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4477/papers?page=13